Edgewise Therapeutics Inc. Common Stock vs Monolithic Power Systems Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Monolithic Power Systems Inc trades at $1,225 (market cap $64.85B). The key difference: Monolithic Power Systems Inc is far larger — about 16.5× Edgewise Therapeutics Inc. Common Stock's market cap, and Monolithic Power Systems Inc pays a 0.61% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Monolithic Power Systems Inc for 25 Days on average.
| EWTX | MPWR | |
|---|---|---|
Market Cap | $3.94B | $64.85B |
Volume | 810,104 | 692,538 |
Sector | Health | Technology |
52-Week High | $48.35 | $1.69K |
52-Week Low | $14.89 | $856.96 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $3.48B | $63.45B |
Dividend Yield | — | 0.61% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MPWR trades at $1,319.55 with minimal daily movement (+0.02%) amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, 24.5% net margins, and robust revenue growth from $2.8B to $3.3B year-over-year. Recent news highlights CEO share sales and a manufacturing partnership with GlobalFoundries to support AI and data center demand. Valuation remains elevated with P/E at 80.5 and P/S at 19.7, reflecting high growth expectations.
The outlook remains positive given analyst consensus (88% buy ratings) and a $1,830 price target, but risks include premium valuation compression, insider selling, and dependence on AI infrastructure growth. Cash flow strength supports dividend payments, though technical weakness near key support at $1,300 requires monitoring for sustained bullish momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →